New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 5, 2012
07:07 EDTENDPEndo Health reports Q3 Branded pharmaceutical sales down 2% to $417M
Net sales of Opana ER decreased 36% for the third quarter on 33 percent lower prescriptions. The decrease in Opana ER net sales is primarily a result of the first quarter supply disruption due to the Novartis plant closure in Lincoln, Neb., and a slower return to growth for Opana ER.
News For ENDP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 28, 2015
09:50 EDTENDPAllergan plans for generic version of Endo's Fortesta blocked, Bloomberg reports
A judge upheld Endo's (ENDP) patents on Fortesta expiring in 2018 and blocked Allergan's (AGN) bid to launch a generic version of the testosterone gel, according to Bloomberg.
August 14, 2015
15:33 EDTENDPEndo confirms court ruling upholding OPANA ER intellectual property
Subscribe for More Information
14:17 EDTENDPEndo jumps 2% after Bloomberg says successful in Opana patent challenge
Subscribe for More Information
14:15 EDTENDPEndo successful in blocking Opana generic until 2023, Bloomberg reports
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use